Skip to main content
Livermore
Livermore
ZHEN

Khurshid Jamal's Form 4 filing

Nukkleus Inc. (NUKK) · filed Feb 17, 2022

Accession no.
0001213900-22-008266
Filed
Feb 17, 2022
Trade date
May 24-Aug 30, 2021
Filing delay
269 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. It was filed 269 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Khurshid JamalCIK 0001874585Officer (Chief Operating Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 30, 2021Common Stock, $0.0001 par value per sharePPurchaseAcquired+11,119,792–F1–37,103,411Direct
May 24, 2021Common Stock, $0.0001 par value per sharePPurchaseAcquired+37,069–F1–25,983,249Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On May 24, 2021, Nukkleus Inc. (the "Company") and the shareholders of Match Financial Limited (the "Match Shareholders"), a private limited company formed in England and Wales ("Match"), entered into a Purchase and Sale Agreement (the "Match Agreement"), pursuant to which the Company, on May 28, 2021, acquired 1,152 ordinary shares of Match representing 70% of the issued and outstanding ordinary shares of Match in consideration of 70,000,000 shares of common stock of the Company (the "Initial Transaction") and issued an option to acquire the balance of Match's outstanding ordinary shares in consideration of 100,000 shares of common stock of the Company. On August 30, 2021, the Company exercised its option pursuant to which it acquired from the Match Shareholders the balance of 493 ordinary shares of Match representing 30% of the issued and outstanding ordinary shares of Match for an additional 30,000,000 shares of common stock of the Company.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)